Antibody discovery and development company MorphoSys has a wealth of experience in designing novel assays for the screening and characterization of therapeutic antibodies. With active programs in oncology, inflammatory and autoimmune diseases, the company’s Discovery, Alliances and TechnologiesDepartment relies on a variety of automated solutions to provide the throughput necessary to support its pipeline.
